ArticleBreast cancer research : BCR2019

MEDI3039, a novel highly potent tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptor 2 agonist, causes regression of orthotopic tumors and inhibits outgrowth of metastatic triple-negative breast cancer.

Yoshimi Endo Greer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.